Microconduit Apparatus with Impedance Sensing for Transdermal Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current transdermal drug delivery methods face challenges such as low transport rates, pain, skin irritation, and inefficiency in delivering therapeutic agents across the stratum corneum, with existing methods like gene guns, ultrasound, and microneedles having limitations in controlling delivery and causing discomfort.
Innovation Solution
An apparatus that creates microconduits in the stratum corneum using an abrasive assembly with an impedance sensing unit to form multiple small holes, allowing for controlled transdermal drug delivery and biopotential measurements by abrading the skin with a mask and abrasive disk, monitored by impedance sensing for precise depth control.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If gene gun or microneedle methods are used to create openings in the stratum corneum, then transdermal delivery capability is improved, but pain and discomfort increase
Solution Approach 1:
The patent replaces mechanical penetration methods (microneedles, gene guns) with an electrochemical field approach. Electrical pulses create microconduits through electroporation and electrochemical reactions, eliminating the need for physical needle penetration while achieving similar transdermal delivery results. This substitution directly resolves the contradiction by maintaining delivery capability while eliminating pain and discomfort associated with mechanical intrusion.
Solution Approach 2:
The patent changes the physical state and properties of the stratum corneum through controlled electrical parameters. By adjusting pulse voltage, duration, and frequency, the system creates temporary microconduits without mechanical damage. This parameter-based control allows precise tuning of the effect to achieve delivery while minimizing harmful effects, resolving the contradiction between delivery capability and patient comfort.
2Measurement precision
If mechanical alteration of the stratum corneum is performed to improve biopotential measurements, then measurement quality is improved, but skin irritation and infection risk increase
Solution Approach 1:
The patent replaces mechanical alteration methods (stripping, scission) with electrochemical field application. Electrical pulses temporarily modify the stratum corneum's electrical properties to enhance signal quality without causing mechanical damage or creating open wounds. This substitution improves measurement precision while eliminating skin irritation and infection risks associated with mechanical alteration.
Solution Approach 2:
The patent employs periodic electrical pulses that temporarily alter skin properties during measurement and then allow natural recovery. The pulsed nature of the treatment creates temporary microconduits for improved signal transmission without causing permanent structural damage, thus improving measurement quality while minimizing harmful effects.
3Ease of operation
If passive transdermal patches are used for drug delivery, then ease of operation is improved, but transport rate is reduced
Solution Approach 1:
The patent employs periodic electrical pulses to temporarily create microconduits in the stratum corneum, dramatically enhancing drug transport rates compared to passive diffusion. The pulsed nature maintains ease of operation (simple application followed by automated pulsing) while achieving active-level delivery speeds, resolving the contradiction between operational simplicity and delivery efficiency.
Solution Approach 2:
The patent introduces an electrical field as an intermediary mechanism between the passive patch and the skin. The electrical pulses act as a mediator that temporarily opens pathways for enhanced drug transport, allowing the system to maintain the ease of passive patch application while achieving active delivery rates through the field-mediated enhancement.
4Productivity
If high voltage pulses are used for electroporation, then transdermal delivery is improved, but skin irritation and equipment complexity increase
Solution Approach 1:
The patent segments the high voltage pulse into multiple lower-voltage pulses applied in sequence. This segmentation achieves the same cumulative electroporation effect while using equipment capable of generating lower individual voltages, thereby reducing equipment complexity while maintaining delivery efficiency. The segmented approach also allows better control and reduced skin irritation.
Solution Approach 2:
The patent uses periodic puling sequences that distribute the total energy delivery over time, allowing tissue recovery between pulses. This periodic approach achieves effective electroporation with lower peak voltages compared to continuous high voltage application, reducing equipment requirements and minimizing skin irritation while maintaining transdermal delivery efficiency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables efficient and controlled transdermal delivery of therapeutic agents and analytes, minimizing discomfort and improving biopotential measurements by forming stable microconduits that allow unhindered molecular transport through the skin, facilitating the delivery of a wide range of molecules and ions.
Implementation Method 1
an impedance sensing unit to form multiple small holes, allowing for controlled transdermal drug delivery and biopotential measurements by abrading the skin with a mask and abrasive disk, monitored by impedance sensing for precise depth control
Implementation Method 2
creates microconduits in the stratum corneum using an abrasive assembly with an impedance sensing unit to form multiple small holes
Implementation Method 3
facilitating the delivery of a wide range of molecules and ions
Data Source
AI summary
Disclosed is an apparatus that creates a number of microconduits, i.e., small holes in the stratum corneum, the outermost layer of human skin tissue, to provide a pathway therethrough, which can be used, for example, for transdermal drug delivery.